rous and transparent process. Importantly, in addition to receiving research funds, grant recipients are provided with career development opportunities. These include mentorships and connections with senior scientists in the field; invitations to present at scientific sessions, lead conference workshops and participate in training and educational webinars; site visits to mentor laboratories to learn new techniques and skills; involvement with pancreatic cancer survivors and their caregivers; and resources to keep them apprised of emerging developments in the field.
This year's Pathway to Leadership Grant recipients are:
- Jennifer M. Bailey, Ph.D., postdoctoral research fellow, Johns Hopkins University School of Medicine
For the initial, mentored phase of Bailey's project, she will work in the laboratories of Steven D. Leach, M.D., and Anirban Maitra, M.D. Maitra received the 2004 AACR-Pancreatic Cancer Action Network Career Development Award, and both organizations are proud to see him now in a position to mentor another young scientist.
Bailey's project, Stop the Start: Novel Insights into PanIN Initiation and Progression, pursues sophisticated studies of the earliest events in pancreatic cancer initiation and progression.
More than 90 percent of pancreatic cancer patients have mutations in a protein called KRAS. Because the exact cell of origin for pancreatic cancer has not been defined, Bailey will develop a "next generation" mouse model of early pancreatic cancer formation, engineering different cell types in the pancreas to express mutated KRAS. Utilizing a fluorescent label attached only to cells with activated KRAS, Bailey will be able to visualize and isolate pancreas cells at various time points following KRAS activation. This way, she can study the effects of mutant KRAS activation in cells before the formation of the earliest known stage of pancreatic cancer development, the pancreatic intraepithPage: 1 2 3 4 Related biology news :1
. Jefferson scientists deliver toxic genes to effectively kill pancreatic cancer cells2
. UC Davis researchers discover Achilles heel in pancreatic cancer3
. Researchers engineer pancreatic cell transplants to evade immune response4
. DNA repair patterns may predict risk of pancreatic cancer5
. U-M researchers ID gene involved in pancreatic cancer6
. Tiny samples could yield big predictive markers for pancreatic cancer7
. HIV-1 protease inhibitor induced oxidative stress in pancreatic B-cells: thymoquinone protection8
. Compendium of pancreatic cancer biomarkers established as strategic approach to early-detection9
. Device protects transplanted pancreatic cells from the immune system10
. Newly discovered epidermal growth factor receptor active in human pancreatic cancers11
. Blood-flow metabolism mismatch predicts pancreatic tumor aggressiveness